Kelli L. Palmer

6.2k citations
86 papers · 4.4k indexed · h-index 33

Kelli L. Palmer

83 papers receiving 4.4k citations

Peers

Kelli L. Palmer
Comparison fields: 5 of 142
  • Molecular Medicine 716
  • Endocrinology 542
  • Infectious Diseases 1.2k
  • Microbiology 393
  • Clinical Biochemistry 395
Replace Eugen Domann with:
Eugen Domann Germany
Giovanni Di Bonaventura Italy
Mohammad Yousef Alikhani Iran
Dragana Vuković Serbia
Kiarash Ghazvini Iran
Gianfranco Donelli Italy
Jean-Christophe Giárd France
Srdjan Stepanović Serbia
Nuno F. Azevedo Portugal
Douglas W. Morck Canada
Kelli L. Palmer relative to Eugen Domann Germany Eugen Domann's profile →
Citations per field
00.5×1.5×2.0×
Eugen Domann · 1×
Citations per year

Countries citing papers authored by Kelli L. Palmer

Since Specialization
Citations

This map shows the geographic impact of Kelli L. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelli L. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelli L. Palmer more than expected).

Fields of papers citing papers by Kelli L. Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelli L. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelli L. Palmer. The network helps show where Kelli L. Palmer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kelli L. Palmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kelli L. Palmer Line = papers co-authored together Kelli L. Palmer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 20242
3 20240
4 20245
5 202313
6 20228
7 20216
8 202117
9 20219
10 202026
11 201990
12 2019121
13 201961
14 201928
15 201825
16 201850
17 201849
18 201767
19 201741
20 2007494

About Kelli L. Palmer

Kelli L. Palmer is a scholar working on Orthodontics, Infectious Diseases and Molecular Medicine, having authored 86 papers that have together received 4.4k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (30 papers), Bacterial biofilms and quorum sensing (18 papers), Bacteriophages and microbial interactions (12 papers), CRISPR and Genetic Engineering (12 papers), Clostridium difficile and Clostridium perfringens research (12 papers), Bacterial Genetics and Biotechnology (11 papers), Streptococcal Infections and Treatments (11 papers) and Dental Implant Techniques and Outcomes (10 papers). The work is most often cited by research in Molecular Medicine (716 citations), Endocrinology (542 citations) and Infectious Diseases (1.2k citations). Kelli L. Palmer has collaborated with scholars based in United States, Brazil and United Kingdom. Frequent co-authors include Michael S. Gilmore, Marvin Whiteley, Marvin Whiteley, Veronica N. Kos, Breck A. Duerkop, Stacie A. Brown, Pradeep K. Singh, Karthik Hullahalli, Wenwen Huo and Danieli C. Rodrigues. Their work appears in journals such as Nature Communications, PLoS ONE and Journal of Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026